Kevin Kuo

Toronto hospital looks to provide life-long care to sickle cell disease patients closer to home globalnews.ca/video/11710497…

Iron deficiency limits hydroxyurea-induced fetal hemoglobin and clinical efficacy in sickle cell disease | Blood | American Society of Hematology ashpublications.org/blood/article/…

Single Cell Hemoglobin Quantification Reveals HbF and HbS Increases in Sickle Erythrocytes from Patients Treated with Hydroxyurea | Blood | American Society of Hematology ashpublications.org/blood/article/…

📣We are pleased to announce that RADeep will participate in the 67th #ASH Annual Meeting and Exposition! ✅This year, we will present four key contributions focused on real-world data, outcome research in hemoglobinopathies, and Europe-wide data standardization efforts.

Kanter J, et al. Implementing linkage coordination: Patient experiences in the recruitment and engagement in care to impact practice enhancement (RECIPE) for SCD study How this translates to less acute care would be important. doi.org/10.1182/blood-… #ASH25

Congratulations Neelan from @uoftmedicine @ihpmeuoft !!! Well done! Sriranjan N, et al. Point of care hemoglobin measurement to streamline clinical decision-making: A single center experience doi.org/10.1182/blood-… #ASH25

Chawla A, et al. Accelerating access to gene therapy: Lessons from commercial implementation in sickle cell disease and transfusion-dependent thalassemia doi.org/10.1182/blood-… #ASH25

Miranda M, et al. The weight of stress: Allostatic load as a predictor of vaso-occlusive episodes in adults with sickle cell disease doi.org/10.1182/blood-… #ASH25

Sanni A, et al. A united-states nationwide analysis of sickle cell genotype-specific differences in inpatient outcomes Some results are thought provoking despite methodological limits. Absolute risk of death was not published but essential. doi.org/10.1182/blood-… #ASH25

📍​Dr. María del Mar Mañú Pereira (RADeep Coordinator and Scientific Coordinator of the @ERNEuroBloodNet & #ENROL) presented “Towards ethical AI in Rare Diseases: data quality and clinical validation for real equity” at the XXXI National Congress on Health Law in Madrid, Spain.